5.20
price up icon0.19%   0.010
after-market Handel nachbörslich: 5.15 -0.05 -0.96%
loading
Schlusskurs vom Vortag:
$5.19
Offen:
$5.15
24-Stunden-Volumen:
215.61K
Relative Volume:
0.88
Marktkapitalisierung:
$168.12M
Einnahmen:
$124.00K
Nettoeinkommen (Verlust:
$-37.94M
KGV:
-4.6847
EPS:
-1.11
Netto-Cashflow:
$-34.70M
1W Leistung:
-4.67%
1M Leistung:
-21.80%
6M Leistung:
-42.35%
1J Leistung:
+670.26%
1-Tages-Spanne:
Value
$5.12
$5.255
1-Wochen-Bereich:
Value
$5.12
$5.50
52-Wochen-Spanne:
Value
$0.75
$14.30

Candel Therapeutics Inc Stock (CADL) Company Profile

Name
Firmenname
Candel Therapeutics Inc
Name
Telefon
617-916-5445
Name
Adresse
117 KENDRICK STREET, NEEDHAM
Name
Mitarbeiter
42
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CADL's Discussions on Twitter

Candel Therapeutics Inc Stock (CADL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-12-02 Eingeleitet H.C. Wainwright Buy
2021-11-19 Eingeleitet BMO Capital Markets Outperform
2021-08-23 Eingeleitet Credit Suisse Outperform
2021-08-23 Eingeleitet Jefferies Buy
2021-08-23 Eingeleitet UBS Buy

Candel Therapeutics Inc Aktie (CADL) Neueste Nachrichten

pulisher
09:58 AM

Candel Therapeutics eyes new indication for CAN-3110 in melanoma following positive preclinical results - Proactive Investors USA

09:58 AM
pulisher
09:01 AM

Candel Therapeutics to Present Preclinical Data at SITC - GlobeNewswire

09:01 AM
pulisher
09:00 AM

Candel Therapeutics to Present Preclinical Data at SITC Annual Meeting Showing Promise for CAN-3110 in Melanoma, Signaling Potential Indication Expansion Beyond Recurrent High-Grade Glioma - StockTitan

09:00 AM
pulisher
Nov 01, 2024

Candel Therapeutics: A Low-Price Oncolytic Virus Plays Further Along Than You Think - Seeking Alpha

Nov 01, 2024
pulisher
Oct 29, 2024

Candel Therapeutics Advances in Cancer Treatment Trials - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

Candel Therapeutics Showcases Innovative Cancer Therapy - GlobeNewswire

Oct 29, 2024
pulisher
Oct 28, 2024

Candel Therapeutics Showcases Innovative Cancer Therapy Candidates at 16th Annual International Oncolytic Virotherapy Conference (IOVC) - StockTitan

Oct 28, 2024
pulisher
Oct 26, 2024

Candel Therapeutics Prices IPO At $8/Share - RTTNews

Oct 26, 2024
pulisher
Oct 26, 2024

Where are the Opportunities in (CADL) - Stock Traders Daily

Oct 26, 2024
pulisher
Oct 17, 2024

Candel Therapeutics Share PriceCADL, RNS News, Articles, Quotes, & Charts (NASDAQ:CADL) - Proactive Investors USA

Oct 17, 2024
pulisher
Oct 17, 2024

Candel Therapeutics Poised for Breakthrough in Cancer Therapies, Key Trials to Read Out by Year-End - Proactive Investors UK

Oct 17, 2024
pulisher
Oct 16, 2024

Candel Therapeutics, Inc. (NASDAQ:CADL) Short Interest Update - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

(CADL) Trading Advice - Stock Traders Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Candel Therapeutics, Inc. (NASDAQ:CADL) Major Shareholder Estuardo Aguilar-Cordova Sells 15,000 Shares - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Candel therapeutics investor sells $243,834 in stock By Investing.com - Investing.com South Africa

Oct 15, 2024
pulisher
Oct 05, 2024

How To Trade (CADL) - Stock Traders Daily

Oct 05, 2024
pulisher
Oct 04, 2024

Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual Meeting - The Manila Times

Oct 04, 2024
pulisher
Oct 04, 2024

Candel Therapeutics to Present Preclinical Data on - GlobeNewswire

Oct 04, 2024
pulisher
Oct 04, 2024

Candel therapeutics insider sells shares worth over $240k By Investing.com - Investing.com South Africa

Oct 04, 2024
pulisher
Oct 04, 2024

Candel therapeutics insider sells shares worth over $240k - Investing.com India

Oct 04, 2024
pulisher
Oct 03, 2024

Candel Therapeutics, Inc. (NASDAQ:CADL) Major Shareholder Estuardo Aguilar-Cordova Sells 1,800 Shares - MarketBeat

Oct 03, 2024
pulisher
Sep 24, 2024

Citigroup Raises Cogent Biosciences (NASDAQ:COGT) Price Target to $15.00 - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Citi raises Cogent price target on bezuclastinib potential - Investing.com India

Sep 24, 2024
pulisher
Sep 24, 2024

Deeper Dive: Understanding Cg Oncology Inc. (CGON) Through its Various Ratios - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

(CADL) Proactive Strategies - Stock Traders Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Gaining Ground: Cogent Biosciences Inc (COGT) Closes Lower at 10.65, Down -3.01 - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

Cg Oncology Inc. [CGON] Stock sold by Insider Song Hong Fang for $23.0 million - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Capricor Therapeutics Shares Rise in Premarket on Plans to File Application for Deramiocel - MarketWatch

Sep 24, 2024
pulisher
Sep 24, 2024

Cintas Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Benzinga

Sep 24, 2024
pulisher
Sep 24, 2024

Farallon Capital Management LLC Decreases Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Kayne Anderson Rudnick Investment Management LLC Trims Holdings in Copart, Inc. (NASDAQ:CPRT) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Circassia Pharmaceuticals Announces Strong H1 2024 Results - TipRanks

Sep 24, 2024
pulisher
Sep 23, 2024

Cadence Design Systems Inc. stock rises Monday, still underperforms market - MarketWatch

Sep 23, 2024
pulisher
Sep 23, 2024

Xponance Inc. Has $24.15 Million Holdings in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Hood River Capital Management LLC Has $13.71 Million Holdings in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Mizuho recommends buying Corbus following its drop post-Novo's obesity data (NASDAQ:CRBP) - Seeking Alpha

Sep 23, 2024
pulisher
Sep 23, 2024

Is it possible to buy Candel Therapeutics Inc(CADL) shares at a good price now? - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by Rhumbline Advisers - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

Mount Yale Investment Advisors LLC Sells 2,003 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Kayne Anderson Rudnick Investment Management LLC Trims Stake in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Revenues Working Against Coherus BioSciences, Inc.'s (NASDAQ:CHRS) Share Price Following 27% Dive - Simply Wall St

Sep 22, 2024
pulisher
Sep 22, 2024

Pacer Advisors Inc. Boosts Holdings in Cross Country Healthcare, Inc. (NASDAQ:CCRN) - MarketBeat

Sep 22, 2024
pulisher
Sep 21, 2024

Sands Capital Ventures LLC Cuts Position in Candel Therapeutics, Inc. (NASDAQ:CADL) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Sands Capital Ventures LLC Trims Stock Position in Candel Therapeutics, Inc. (NASDAQ:CADL) - MarketBeat

Sep 21, 2024
pulisher
Sep 20, 2024

Davidson Capital Management Inc. Buys 11,978 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Did Candel Therapeutics Inc (CADL) perform well in the last session? - US Post News

Sep 20, 2024
pulisher
Sep 20, 2024

Corbus drops after rival Novo Nordisk reports obesity drug data - XM

Sep 20, 2024
pulisher
Sep 20, 2024

Choreo LLC Purchases Shares of 23,033 Coty Inc. (NYSE:COTY) - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

Cadence design systems director sells $414k in company stock - Investing.com

Sep 19, 2024
pulisher
Sep 19, 2024

Sienna Gestion Trims Stake in Copart, Inc. (NASDAQ:CPRT) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Catalyst Pharmaceuticals stock hits 52-week high at $20.88 - Investing.com

Sep 19, 2024

Finanzdaten der Candel Therapeutics Inc-Aktie (CADL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Candel Therapeutics Inc-Aktie (CADL) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Aguilar-Cordova Estuardo
10% Owner
Oct 14 '24
Sale
6.02
15,000
90,300
929,873
Aguilar-Cordova Estuardo
10% Owner
Oct 15 '24
Sale
6.03
10,412
62,784
919,461
Aguilar-Cordova Estuardo
10% Owner
Oct 02 '24
Sale
6.92
26,988
186,757
961,673
Aguilar-Cordova Estuardo
10% Owner
Oct 03 '24
Sale
6.85
1,800
12,330
959,873
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):